相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi et al.
LANCET (2022)
Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis
Ruijun Han et al.
BRAIN AND BEHAVIOR (2022)
Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study
Tariq Chukir et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2021)
The Relationship Between Food Craving, Appetite-Related Hormones and Clinical Parameters in Bipolar Disorder
Martina Platzer et al.
NUTRIENTS (2021)
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia
Shira Weizman et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
Carla Rognoni et al.
CLINICAL DRUG INVESTIGATION (2021)
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial
Thomas A. Wadden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia Prevalence, Antipsychotic Specificities, and Changes Over Time
Renaud de Beaurepaire
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial
Melanie Davies et al.
LANCET (2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review
Anoop Sankaranarayanan et al.
NUTRIENTS (2021)
Safety of antipsychotic drugs: A systematic review of disproportionality analysis studies
Dainora Cepaityte et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial
Domenica Rubino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effect of liraglutide 3.0mg treatment on weight reduction in obese antipsychotic-treated patients
Seung Eun Lee et al.
PSYCHIATRY RESEARCH (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis
Barbara B. Barton et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study
Giuseppe Cicala et al.
FRONTIERS IN PSYCHIATRY (2020)
Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting A Randomized Pilot Trial
Rudolph M. Navari et al.
JAMA ONCOLOGY (2020)
The insight paradox in schizophrenia: A meta-analysis of the relationship between clinical insight and quality of life
Beshaun J. Davis et al.
SCHIZOPHRENIA RESEARCH (2020)
Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antipsychotic Medications Palliate Symptoms in Children with Cancer
Orit Peled et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2020)
Biopsychosocial factors associated with disordered eating behaviors in schizophrenia
Mohsen Khosravi
ANNALS OF GENERAL PSYCHIATRY (2020)
Associations Between Two Domains of Social Adversity and Recovery Among Persons with Serious Mental Illnesses Being Treated in Community Mental Health Centers
Michael T. Compton et al.
COMMUNITY MENTAL HEALTH JOURNAL (2020)
Assessment of the relationship between food addiction and nutritional status in schizophrenic patients
Ozge Kucukerdonmez et al.
NUTRITIONAL NEUROSCIENCE (2019)
Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial
Richard I. G. Holt et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Low-dose of olanzapine has ameliorating effects on cancer-related anorexia
Hideki Okamoto et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Food craving and consumption evolution in patients starting treatment with clozapine
Marina Garriga et al.
PSYCHOPHARMACOLOGY (2019)
Effects of antidepressant and antipsychotic use on weight gain: A systematic review
Lucia Alonso-Pedrero et al.
OBESITY REVIEWS (2019)
Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication
Rachel Morell et al.
PSYCHIATRY RESEARCH (2019)
WFSBP guidelines on how to grade treatment evidence for clinical guideline development
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis
Dan J. Siskind et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2018)
Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update
Jennifer Pillay et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Prescribing Trends of Atypical Antipsychotic Drugs in an Outpatient Unit of a Child and Adolescent Clinic in Turkey
Cigdem Yektas et al.
CLINICAL NEUROPHARMACOLOGY (2018)
Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews
Esther Leticia Amorim Ribeiro et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo
Jacob S. Ballon et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Dietary patterns and physical activity in people with schizophrenia and increased waist circumference
Ane Storch Jakobsen et al.
SCHIZOPHRENIA RESEARCH (2018)
Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients
Julia Margaret Lappin et al.
SCHIZOPHRENIA RESEARCH (2018)
Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial
Ane Storch Jakobsen et al.
SCHIZOPHRENIA RESEARCH (2018)
Risperidone But Not Quetiapine Treatment Is Associated With Increased Appetite But Not Satiety Hormones in Children During An Oral Glucose Tolerance Test: A Pilot Study
Ying Fai Ngai et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Is Obesity in Young People With Psychosis a Foregone Conclusion? Markedly Excessive Energy Intake Is Evident Soon After Antipsychotic Initiation
Scott B. Teasdale et al.
FRONTIERS IN PSYCHIATRY (2018)
Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations
Yuri Milaneschi et al.
JAMA PSYCHIATRY (2017)
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder A Randomized Clinical Trial
Julie R. Larsen et al.
JAMA PSYCHIATRY (2017)
A Retrospective Study of Long Acting Risperidone Use to Support Treatment Adherence in Youth with Conduct Disorder
Sevcan Karakoc Demirkaya et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2017)
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Madhubhashinee Dayabandara et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents
Nopphadol Nuntamool et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Exploration of food addiction in people living with schizophrenia
Ivana Goluza et al.
ASIAN JOURNAL OF PSYCHIATRY (2017)
Neural changes induced by antipsychotic administration in adolescence: A review of studies in laboratory rodents
Aung Aung Kywe Moe et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder
Lawrence Scahill et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2016)
Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial
Ahmad Ghanizadeh
ANNALS OF GENERAL PSYCHIATRY (2016)
Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials
Ying Jiao Zhao et al.
BJPSYCH OPEN (2016)
Factors Associated With Hyperphagic Behavior in Patients With Dementia Living at Home
Lu-Wen Chi et al.
BIOLOGICAL RESEARCH FOR NURSING (2015)
Latest approaches for the treatment of obesity
V. Margaret Jackson et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men
Elsa Daurignac et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2015)
Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial
Michael Aman et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2015)
Metabolic Impairments Precede Changes in Hunger and Food Intake Following Short-Term Administration of Second-Generation Antipsychotics
Karen L. Teff et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Asena pine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder
Robert L. Findling et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2015)
Appetite control and energy balance: impact of exercise
J. E. Blundell et al.
OBESITY REVIEWS (2015)
Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants
Hubertus Himmerich et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2015)
An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service
Inti Qurashi et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Comparison of Low and Moderate Dosages of Extended-Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Donald W. Black et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Aripiprazole use in Children and Adolescents: A Public Hospital Child Psychiatry Outpatient Department's Experience
Saziye Senem Basgul
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Clinical Effectiveness of Aripiprazole in Short-term Treatment of Tic Disorder in Children and Adolescents: A Naturalistic Study
Che-Sheng Ho et al.
PEDIATRICS AND NEONATOLOGY (2014)
Aripiprazole Versus Risperidone for Treating Children and Adolescents with Tic Disorder: A Randomized Double Blind Clinical Trial
Ahmad Ghanizadeh et al.
CHILD PSYCHIATRY & HUMAN DEVELOPMENT (2014)
Antipsychotic induced metabolic changes & treatment response: A prospective study
Eesha Sharma et al.
ASIAN JOURNAL OF PSYCHIATRY (2014)
Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study
Subin Park et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2013)
Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
Karen L. Teff et al.
DIABETES (2013)
Hunger and negative alliesthesia to aspartame and sucrose in patients treated with antipsychotic drugs and controls
Y. Khazaal et al.
Eating and Weight Disorders-Studies on Anorexia Bulimia and Obesity (2013)
Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance
Chao Deng
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2013)
Features of problematic eating behaviors among community-dwelling older adults with dementia: Family caregivers' experience
Hua-Chen Hsiao et al.
GERIATRIC NURSING (2013)
Olanzapine and food craving: a case control study
Mohammed J. Abbas et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Iron Deficiency in Pediatric Patients in Long-Term Risperidone Treatment
Chadi Albert Calarge et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2013)
Are Non-Serious Adverse Reactions to Psychiatric Drugs Really Non-Serious?
Marco Pozzi et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2013)
Quetiapine Monotherapy in Adolescents with Bipolar Disorder Comorbid with Conduct Disorder
Gabriele Masi et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2013)
An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder
Justine M. Kent et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2013)
Psychotropic drug prescribing in an Australian specialist child and adolescent eating disorder service: a retrospective study
Julia K. Moore et al.
JOURNAL OF EATING DISORDERS (2013)
Risperidone Dosing in Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study
Justine M. Kent et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2013)
A Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients
Raye Z. Litten et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Neural Correlates of Weight Gain With Olanzapine
Jose Mathews et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
An Overview of Treatments for Obesity in a Population With Mental Illness
Valerie H. Taylor et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2012)
Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients
Shefali Srivastava et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Switching to aripiprazole in subjects with Pervasive Developmental Disorders showing tolerability issues with risperidone
Makoto Ishitobi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients
Robert C. Smith et al.
PSYCHIATRY RESEARCH (2012)
Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment
E. Stip et al.
TRANSLATIONAL PSYCHIATRY (2012)
Correlates of weight gain during long-term risperidone treatment in children and adolescents
Chadi Calarge et al.
Child and Adolescent Psychiatry and Mental Health (2012)
Subjective and Biological Weight-Related Parameters in Adolescents and Young Adults with Schizophrenia Spectrum Disorder under Clozapine or Olanzapine Treatment
Christian J. Bachmann et al.
ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE (2012)
Atypical Antipsychotic-Induced Weight Gain Insights into Mechanisms of Action
James L. Roerig et al.
CNS DRUGS (2011)
An Open-Label Study of Aripiprazole in Children with a Bipolar Disorder
Robert L. Findling et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Risperidone treatment in preschool children with disruptive behavior disorders: a chart review study / Yıkıcı davranış bozuklukları olan okulöncesi çocuklarda risperidon tedavisi: Bir dosya tarama çalışması
Murat Coskun et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
Lawrence Maayan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
Robert J. Fountaine et al.
OBESITY (2010)
Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study
Istvan Bitter et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Assessing various aspects of the motivation to eat that can affect food intake and body weight control
F. Bellisle
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2009)
Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients
Othman Sentissi et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
Aripiprazole in Children and Adolescents with Tourette's Disorder: An Open-Label Safety and Tolerability Study
Gholson J. Lyon et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study
J. Karagianis et al.
SCHIZOPHRENIA RESEARCH (2009)
Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study
Tamas Treuer et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Adiposity and eating behaviors in patients under second generation antipsychotics
Melissa Blouin et al.
OBESITY (2008)
Clozapine and olanzapine are associated with food craving and binge eating -: Results from a randomized double-blind study
Michael Kluge et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders
S. Gebhardt et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study
Michael Poyurovsky et al.
PSYCHOPHARMACOLOGY (2007)
Medicare's search for effective obesity treatments - Diets are not the answer
Traci Mann et al.
AMERICAN PSYCHOLOGIST (2007)
Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase
Sangwon F. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia
Maria Luisa Onor et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Risperidone in children with autism: Randomized, placebo-controlled, double-blind study
Ravishankar Nagaraj et al.
JOURNAL OF CHILD NEUROLOGY (2006)
A crossover study of risperidone in children, adolescents and adults with mental retardation
Jessica A. Hellings et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2006)
Prevalence of the night eating syndrome in a psychiatric population
JD Lundgren et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study
Ronald L. Lindsay et al.
JOURNAL OF INTELLECTUAL & DEVELOPMENTAL DISABILITY (2006)
Acute and long-term safety and tolerability of risperidone in children with autism
MG Aman et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2005)
Long-term effects of risperidone in children with autism spectrum disorders: A placebo discontinuation study
PW Troost et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2005)
A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors
JL Roerig et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders
BJ Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Olanzapine increases plasma ghrelin level in patients with schizophrenia
M Murashita et al.
PSYCHONEUROENDOCRINOLOGY (2005)
A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder
J Guardia et al.
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Risperidone treatment of children with autistic disorder:: Effectiveness, tolerability, and pharmacokinetic implications
A Gagliano et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2004)
Dopamine partial agonists - A new class of antipsychotic
JA Lieberman
CNS DRUGS (2004)
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study
M Tohen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: A double-blind, placebo-controlled study
M Poyurovsky et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
A prospective, open-label trial of olanzapine in adolescents with schizophrenia
RL Findling et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2003)
Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine
FM Theisen et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Open-label study of olanzapine in children with pervasive developmental disorder
C Kemner et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs
R Snyder et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Risperidone in children with autism and serious behavioral problems
JT McCracken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Olanzapine versus divalproex in the treatment of acute mania
M Tohen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine
D Gothelf et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Risperidone treatment in children and adolescents with autism: Short- and long-term safety and effectiveness
RP Malone et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Clozapine and haloperidol in moderately refractory schizophrenia - A 6-month randomized and double-blind comparison
JM Kane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America
JACE Silva et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia
BJ Kinon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
分享论文
